Topical methotrexate 1% gel for treatment of vitiligo: A case report and review of the literature

Dermatol Ther. 2019 Sep;32(5):e13013. doi: 10.1111/dth.13013. Epub 2019 Jul 16.

Abstract

Vitiligo is quite a common hypopigmentary disorder, which may affect both children and adults with important psychological effects due to the well-known leopard skin-like appearance. Even if asymptomatic and not life threatening, vitiligo has to be increasingly studied and treated. Hitherto, the efficacy of topical methotrexate in treatment of vitiligo has not been reported. We herein reporting our preliminary observation on the promising efficacy of topical methotrexate in one patient with stable vitiligo. The patient applied topical methotrexate 1% gel twice daily for 12 weeks. Significant improvement of the lesion with no local or systemic side effects were noted during the course of therapy. We propose that this well-tolerated drug can be used for vitiligo therapy; however, further investigations should be performed to ascertain the exact topically effective dose.

Keywords: methotrexate; topical; vitiligo.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Administration, Topical
  • Dermatologic Agents / administration & dosage
  • Dose-Response Relationship, Drug
  • Female
  • Gels
  • Humans
  • Methotrexate / administration & dosage*
  • Skin / pathology*
  • Skin Pigmentation / drug effects*
  • Vitiligo / diagnosis
  • Vitiligo / drug therapy*
  • Young Adult

Substances

  • Dermatologic Agents
  • Gels
  • Methotrexate